New York Life Investment Management »

Ptc Therapeutics I shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $371k 13k 29.09
2023-06-30 $346k 8.5k 40.67
2023-03-31 $475k 9.8k 48.44

More positions owned by New York Life Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Indexiq Etf Tr Candriam Us Larg (IQSU)
Amazon (AMZN)
Indexiq Active Etf Tr Iq Mackay Esg Cr (ESGB)
Indexiq Etf Tr Candriam Us Mid (IQSM)
Indexiq Etf Tr Iq 500 Int Etf (IQIN)
Indexiq Etf Tr Candriam Interna (IQSI)
Meta Platforms Cl A (META)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Indexiq Etf Tr Iq U.s. Small Ca (CSML)
Alphabet Cap Stk Cl A (GOOGL)
Indexiq Etf Tr Iq Cbre Nexgen (ROOF)
Indexiq Etf Tr Ftse Internl Eqt (HFXI)

View all positions for New York Life Investment Management

Top funds holding Ptc Therapeutics I

Wellington Management Company
Vanguard Group
BlackRock
Armistice Capital
Cowen And Company
Henderson Group
Morgan Stanley
FMR
Geode Capital Management
Jacobs Levy Equity Management
Franklin Resources
First Trust Advisors
Adage Capital Partners GP
D. E. Shaw & Co
Blackstone Group

View all funds holding Ptc Therapeutics I